This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Japan Tobacco plans to further pursue Quantum AI in molecular design following these early results.

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications ...

The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, reaching ...

UC San Diego researchers reveal PHGDH as a causal gene in Alzheimer's, linking its regulatory role to disease progression and ...

Artificial Intelligence (AI) is no longer a futuristic idea in healthcare; it is reshaping the industry right now, and 2025 ...

Synergistic application of AI-based generative chemistry and free energy methods streamlines molecule discovery and ...

Carterra Inc, a provider of innovative technologies, is partnering with ImmunoPrecise Antibodies (IPA), ACROBiosystems, and ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...